Quote:

---

I also want to recognize and thank our investors who have shown tremendous patience and faith while CytoDyn steadies the course and moves toward open waters.

---

To me, it’s clear the roughest seas are behind us, and the path ahead looks much smoother. That said, we know from experience that whenever a catalyst drives meaningful price appreciation, the calm waters can quickly attract storms, sharks, and shorts.

I look forward to the day when leronlimab grows into a true giant—a whale, or even a megalodon—within the vast ocean of therapies. There will always be turbulence and powerful currents along the way, but I remain confident this remarkable drug can endure the voyage and ultimately rescue many weary passengers—and investors—still aboard.